Effective treatment with intravenous immunoglobulin for Henoch–Schönlein purpura with refractory gastrointestinal symptoms in an adolescent: A CARE-compliant case report
Liji Chen,Cailing Zhong,Longxiu Fan,Ming Luo,Linkun Cai,Beiping Zhang,Haiyan Zhang
DOI: https://doi.org/10.1097/md.0000000000040370
IF: 1.6
2024-11-06
Medicine
Abstract:Henoch–Schönlein purpura (HSP), also known as immunoglobulin A vasculitis, [ 1 ] is a common systemic vasculitis in children, with an annual incidence of 3 to 55.9/100,000. [ 2–4 ] HSP can involve the skin, joints, gastrointestinal (GI) tract, and kidneys, with typical symptoms including purpura, abdominal pain, and arthralgia. In most cases, the initial symptom is skin purpura, whereas abdominal pain is less frequently observed as the first sign. [ 5–7 ] When GI manifestations occur without accompanying purpura, establishing a definitive diagnosis can be challenging, often leading to misdiagnosis. For patients with severe abdominal pain, corticosteroid (CS) therapy is a common treatment. However, some HSP patients with refractory GI symptoms do not respond even to CS. In such instances, intravenous immunoglobulin (IVIG) is considered as a second-line treatment option. Currently, there is no consensus or standardized guidelines on the use of IVIG for HSP, particularly in patients with complex GI manifestations. Herein, we present an atypical case of HSP, characterized by complex GI manifestations as the initial symptom. Initially, CS therapy was ineffective, but after the combined administration of IVIG, the patient's abdominal pain, petechiae, and joint pain were completely alleviated. The case report has been structured according to the CARE checklist.
medicine, general & internal